In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 4, 2002, Pages 328-334

  Prats, G ^a   Roig, C ^a   Miro E ^a   Navarro, F ^a   Mirelis, B ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AF 3013; ANTIMIGRAINE AGENT; CIPROFLOXACIN; DRUG METABOLITE; GREPAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENCY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; DIOXOLANES; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; QUINOLONES;

EID: 0036249985     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0709-1     Document Type: Article

References (10)

1. In vitro activity of Bay 09867, a new quinolone derivative, compared with that of other antimicrobial agents
2. Fluoroquinolone antimicrobial agents
3. In vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates
4. In vitro activity of Bay 12-8039, a new fluoroquinolone
5. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116
6. In vivo evaluation of NM441, a new thiazeto-quinoline derivative
7. Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone
8. In vitro antibacterial activity of a new quinolone, NM394
9. Pharmacokinetics and safety of NM441, a new quinolone in healthy male volunteers